IL162349A0 - Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives - Google Patents

Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives

Info

Publication number
IL162349A0
IL162349A0 IL16234902A IL16234902A IL162349A0 IL 162349 A0 IL162349 A0 IL 162349A0 IL 16234902 A IL16234902 A IL 16234902A IL 16234902 A IL16234902 A IL 16234902A IL 162349 A0 IL162349 A0 IL 162349A0
Authority
IL
Israel
Prior art keywords
fused
trans
preparation
büfuran
dibenzo
Prior art date
Application number
IL16234902A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL162349A0 publication Critical patent/IL162349A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
IL16234902A 2001-12-07 2002-12-02 Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives IL162349A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204961 2001-12-07
PCT/EP2002/013560 WO2003048146A1 (en) 2001-12-07 2002-12-02 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES

Publications (1)

Publication Number Publication Date
IL162349A0 true IL162349A0 (en) 2005-11-20

Family

ID=8181460

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16234902A IL162349A0 (en) 2001-12-07 2002-12-02 Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives

Country Status (21)

Country Link
US (2) US6998494B2 (hr)
EP (1) EP1456193B1 (hr)
JP (1) JP4516752B2 (hr)
KR (1) KR20050044329A (hr)
CN (1) CN1293066C (hr)
AT (1) ATE294168T1 (hr)
AU (1) AU2002342926B2 (hr)
BR (1) BR0214068A (hr)
CA (1) CA2468038C (hr)
DE (1) DE60203937T2 (hr)
ES (1) ES2242076T3 (hr)
HK (1) HK1076461A1 (hr)
HR (1) HRP20040490A2 (hr)
HU (1) HUP0402152A3 (hr)
IL (1) IL162349A0 (hr)
MX (1) MXPA04005400A (hr)
NO (1) NO20042884L (hr)
NZ (1) NZ532806A (hr)
PL (1) PL369585A1 (hr)
WO (1) WO2003048146A1 (hr)
ZA (1) ZA200404394B (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0214068A (pt) * 2001-12-07 2004-10-13 Janssen Pharmaceutica Nv Preparação de derivados 3,3a,8,12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b] furano transfundidos
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
AU2005251948A1 (en) * 2004-06-14 2005-12-22 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives
AU2005279211B2 (en) * 2004-08-31 2011-07-28 Janssen Pharmaceutica N.V. Process for the production of [2- (4-fluoro-benzyl) -phenyl] -acetic acid
AU2005313325C1 (en) 2004-12-07 2011-11-10 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
AU2006209397B2 (en) 2005-01-27 2011-04-07 Janssen Pharmaceutica N.V. Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders
MX2007016247A (es) 2005-06-17 2008-03-10 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos novedosos que contienen una cadena lateral de amida ciclica.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100389298B1 (ko) * 1996-04-12 2003-10-30 얀센 파마슈티카 엔.브이. 치환된테트라사이클릭테트라하이드로퓨란유도체
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
BR0214068A (pt) * 2001-12-07 2004-10-13 Janssen Pharmaceutica Nv Preparação de derivados 3,3a,8,12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b] furano transfundidos
CN1697833A (zh) * 2001-12-07 2005-11-16 詹森药业有限公司 顺式－稠合的3,3a,8,12b－四氢－2H－二苯并[3,4:6,7]环庚并[1,2－b]呋喃衍生物的制备方法

Also Published As

Publication number Publication date
ZA200404394B (en) 2005-09-05
WO2003048146A1 (en) 2003-06-12
MXPA04005400A (es) 2004-10-11
US20050228043A1 (en) 2005-10-13
CA2468038A1 (en) 2003-06-12
EP1456193A1 (en) 2004-09-15
ATE294168T1 (de) 2005-05-15
CN1293066C (zh) 2007-01-03
ES2242076T3 (es) 2005-11-01
DE60203937D1 (de) 2005-06-02
HUP0402152A3 (en) 2007-03-28
KR20050044329A (ko) 2005-05-12
JP4516752B2 (ja) 2010-08-04
US20050014820A1 (en) 2005-01-20
JP2005511691A (ja) 2005-04-28
AU2002342926B2 (en) 2009-02-26
EP1456193B1 (en) 2005-04-27
HK1076461A1 (en) 2006-01-20
NO20042884L (no) 2004-07-07
AU2002342926A1 (en) 2003-06-17
CN1602306A (zh) 2005-03-30
HRP20040490A2 (en) 2004-10-31
DE60203937T2 (de) 2006-05-11
CA2468038C (en) 2011-04-26
US6998494B2 (en) 2006-02-14
BR0214068A (pt) 2004-10-13
HUP0402152A2 (hu) 2005-02-28
NZ532806A (en) 2006-01-27
PL369585A1 (en) 2005-05-02

Similar Documents

Publication Publication Date Title
HK1076461A1 (en) Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzoÄ3,4;6,7ÜcycloheptaÄ1,2-bÜfuran derivatives
NZ522568A (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
AUPR213700A0 (en) Antiviral agents
HK1071129A1 (en) Novel compounds
YU2101A (sh) Antiparazitski derivati artemisinina (endoperoksidi)
CA2445306A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
MXPA04000755A (es) Nuevos compuestos.
HK1070063A1 (en) Stable polymorph of flibanserin, technical processfor its preparation and the use thereof for prepa ring medicaments
MXPA03012013A (es) Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor.
YU94103A (sh) Novi derivati sulfonske kiseline
TNSN07485A1 (fr) Derives de n-(arylalkyl)-1h-pyrrolopyridine -2- carboxamides, leur preparation et leur application en therapeutique
HU895657D0 (en) Process for the preparation of mevalonolactones containing thienopyridine ring and pharmaceutical compositions containing such acitve ingredients
MXPA04005399A (es) Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano.
WO2001056992A3 (en) Dibenzo (b,f) azepine intermediates
AU6220300A (en) Benzofurylpiperazine serotonin agonists
HK1043784A1 (en) Processes for preparing pesticidal intermediates.
MXPA05008400A (es) Derivados de oxazolidinona n-sustituidos por un anillo triciclico, para su uso como agentes antibacterianos.
WO2004065360A3 (en) Piperazine derivatives and their use as synthesis intermediates
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
MXPA02003639A (es) Proceso nuevo para la sintesis de (3as)-5, 5-dioxo-2, 3, 3a-4- tetrahidro-1h-pirrolo[2, 1c][1, 2, 4] benzotiadiazina.
EE200300058A (et) Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel
EP1241167A4 (en) DERIVATIVES OF 3-ETHYL-, 3-PROPYL-, OR 3-BUTYL-CHROMANE AND -THIOCHROMANE
MXPA03003466A (es) Derivados de piranosido.
CA2323315A1 (en) Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees